Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02513043 · ClinicalTrials.gov registry record

Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine

A clinical trial of Pregnancy, sponsored by Gynuity Health Projects.

Completed
Registry status
1,470
Enrollment target
17
Study locations

NCT02513043 is a study of Pregnancy that has completed, run by Gynuity Health Projects. The registered enrollment target is 1,470 participants, above the 865-participant average among 191 other Pregnancy trials with a reported enrollment target (70% higher). The trial reports 17 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02513043, a study of Pregnancy, has completed, sponsored by Gynuity Health Projects.

COMPLETED
Registry status
1,470 participants
Enrollment target
17
Study locations

Study Summary

This pilot study is designed to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.

Conditions Studied

Interventions

  • DRUG medical abortion

Study Locations (17)

New York

  • Choices Women's Medical Center - Jamaica
  • Maine Family Planning - New York

Oregon

  • Planned Parenthood Columbia Willamette - Portland
  • Oregon Health and Sciences University Women's Health Research Unit - Portland

Washington

  • Planned Parenthood Columbia Willamette - Washington
  • Oregon Health and Sciences University Women's Health Research Unit - Washington

Colorado

  • Planned Parenthood of the Rocky Mountains - Denver

District of Columbia

  • Carafem - Washington D.C.

Georgia

  • Carafem - Atlanta

Hawaii

  • The University of Hawaii Women's Options Centers - Honolulu

Illinois

  • Carafem - Skokie

Trial Details

FieldValue
Enrollment Target 1,470 participants
Start Date 2016-03-22
Est. Completion 2021-05-11

Sponsor

Gynuity Health Projects

29 total trials

What the Registry Record Tells You About NCT02513043

The ClinicalTrials.gov registry entry for NCT02513043 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,470 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 865-participant average among 191 other Pregnancy trials with a reported enrollment target (70% higher). The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which medical abortion is the first listed.

NCT02513043 reports 17 study locations spanning 14 distinct geographic areas - top geographies include New York, Oregon, Washington.

Frequently Asked Questions

What is clinical trial NCT02513043 about?

NCT02513043 is a clinical study titled "Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine". This pilot study is designed to obtain preliminary data on the safety, acceptability, and feasibility of direct-to-consumer telemedicine abortion.

What is the current status of trial NCT02513043?

This trial is currently completed. The enrollment target is 1,470 participants. The study started on 2016-03-22. Estimated completion is 2021-05-11.

What conditions does trial NCT02513043 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT02513043?

The interventions under investigation include: medical abortion (DRUG).

Who is sponsoring clinical trial NCT02513043?

This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02513043 being conducted?

This trial has 17 study locations across Colorado, District of Columbia, Georgia, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.